ACCC 37th National Oncology Conference [On-Demand]

image

The leading conference for innovation in cancer care delivery is now available on-demand!

Discover the convenience of viewing the ACCC 37th [Virtual] National Oncology Conference (#ACCCNOC) content from your home or office.

If you registered for the virtual conference in September, on-demand access is included in your registration. You can revisit the sessions for a deeper dive or catch the presentations you didn’t have time to watch. 

Participation in the enduring activities of the ACCC 37th National Oncology Conference will be available for 12 months and will award continuing education hours for physicians, nurses, pharmacists, and administrators as appropriate.

If you haven’t registered yet, it’s not too late!  Click the green Register button in the upper right corner of this page to purchase the #ACCCNOC on-demand content package.

Registration Type

Registration Fee

ACCC Member 

ACCC Cancer Program Members, Individual Provider Members,
ACCC Individual Consultants, Industry Members,
and members of the Oncology State Societies at ACCC

$100.00

Non-member Provider & Industry

Individuals who are employed by a cancer program, practice, non-profit organization,
consulting company, pharmaceutical/device manufacturer,
diagnostic testing company, or technology/analytics company

$300.00

 

ACCC Industry Advisory, Emerging Companies, and Technical Advisory Council Members and employees of sponsor companies of the ACCC 37th [Virtual] National Oncology Conference are entitled to a free registration. If you are not yet registered, please contact Mike Andrews, Senior Director, Corporate Relations or Don Cooksey, Senior Manager, Exhibit Sales & Corporate Relations for further assistance.

#ACCCNOC On-Demand Highlights:

  • Learn from your device where it’s convenient for you—watch presentations on your computer, tablet, or smartphone
  • Relive the conference experience with presentation slides with synchronized audio and video
  • Access more than 10 hours of breakout sessions and keynote presentations
  • Learn on your schedule with 24/7 online access
  • Personalize your #ACCCNOC On-Demand learning experience by tailoring your professional development to your own interests—on your own time.

For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing this content. 

 If you have any questions or feedback, please feel free to email us.

#ACCCNOC On-Demand allows you to watch and re-watch sessions on your own time, with a better ability to: 
  • Review leadership strategies to enhance resilience among teams and organizations in response to adversities and to review strategies to improve the quality of cancer care 
  • Integrate innovative approaches for onboarding experienced non-oncology nurses to address staffing shortages 
  • Use targeted management algorithms to identify patient co-morbidities aiming to reduce hospital and emergency department admissions 
  • Discuss the benefits of creating and implementing a collaborative pharmacist practice agreement to improve oral oncolytic workflow and reduce treatment delays
  • Explore the use of a 3D-printed lung nodule educational tool to help providers educate patients, reduce distress, and engage in shared decision-making 
  • Outline approaches to implement a nurse navigator-led community-based cardio-oncology clinic to manage cardio-toxic side effects in oncology patients and improve patient quality of life 
  • Identify clinical variables associated with increased risk of hospital and emergency department admissions using predictive modeling and proactively manage patients to reduce readmissions after chemotherapy 
  • Adapt a transition plan to administer chemotherapy in the outpatient setting to improve care, lower infection rates, improve quality of life, and reduce cost of care 
  • Investigate the role of prehab, rehab, and prospective surveillance in improving patient experience, reducing hospital stay, early identification of physical impairments, functional limitations, and/or treatment restrictions, and in palliative care for patients with advanced cancer 
  • Examine strategies to address the disparities faced by women in oncology 

Participation in the enduring activities of the ACCC 37th National Oncology Conference (#ACCCNOC) will be available for 12 months and will award continuing education hours for physicians, nurses, pharmacists, and administrators as appropriate.

The breakdown of accreditation(s) per session and hour(s) offered are as follow: 

 

Accreditation (s) Offered

Title 

CME 

CPE 

CNE 

ACHE-Q 

Onboarding Experienced Non-Oncology Nurses to Address Staffing Shortages: Development of a Transitional Oncology Training Academy 

0.5 

0.5 

Utilizing Technology to Identify Patient Co-Morbidities and Reduce Hospital and ED Admissions 

1.25 

1.25 

Improve Oral Oncolytic Workflow and Reduce Treatment Delays with a Pharmacist Collaborative Practice Agreement 

1.25 

1.25 

1.25 

1.25 

Leveraging a 3D Lung Nodule Educational Tool to Reduce Patient Distress 

A Nurse Navigator-Led Community-Based Cardio-Oncology Clinic 

1.25 

Reducing Readmissions after Chemotherapy with Predictive Modeling of Risk Factors 

1.25 

1.25 

1.25 

Shifting Chemo Administration from Inpatient to Outpatient Setting Improves Care and Reduces Costs 

1.25 

1.25 

1.25 

1.25 

Integration of Prehab, Rehab, and Prospective Surveillance into Interdisciplinary Teams 

1.25 

1.25 

Total Hours 

3.75 

2.5 

8.0 

6.75 

  • Leadership Resilience and Post Traumatic Growth

    Contains 1 Component(s)

    Presented at the 37th [Virtual] National Oncology Conference

    Greg Hiebert

    Leadership Educator, (Coach) and Consultant LeadershipForward

    Following his passion for leadership, Greg started leadershipForward in 2002 to provide clients with leadership development solutions at the senior and operational leadership levels in the private, public and non-profit sectors. Greg has coached over 650 executives and developed and facilitated over 350 leadership programs over the last 18 years. Greg started his leadership journey at the United States Military Academy, and after graduation served in several elite Army units. After receiving his MBA from the Harvard Business School, Greg taught leadership and organizational change at the United States Military Academy and earned the highest educator ratings for teaching excellence. Greg was recruited to McKinsey & Company and focused on issues of leadership and organizational change. Greg then served in several senior executive leadership roles at BellSouth Telecommunications and several high technology firms. He was recruited to an executive search firm, Egon Zehnder International, serving clients in executive search and assessment, succession planning, leadership development, and organizational effectiveness. Greg has been married for 39 years to Claudia, a retired pediatric nurse. They have 4 adult children and three grandchildren and live in Atlanta, Georgia.

  • Onboarding Experienced Non-Oncology Nurses to Address Staffing Shortages: Development of a Transitional Oncology Training Academy

    Contains 5 Component(s), Includes Credits

    Presented at the 37th [Virtual] National Oncology Conference

    Onboarding Experienced Non-Oncology Nurses to Address Staffing Shortages: Development of a Transitional Oncology Training Academy

    ACCC 37th National Oncology Conference

    This educational activity is jointly provided by AXIS Medical Education and ACCC

    This activity is supported by educational grants from Abbvie,  AstraZeneca, GlaxoSmithKline, Lilly and Pfizer, Inc.

    Release Date: 10/16/2020

    Expire Date: 10/15/2021

    Estimated Time to Complete: 30 minutes

    Target audience: Nurse and APPs with an interest n oncology care, nurse educators, and cancer program administrators

    Overview: This 12-week academy at Miami Cancer Institute gives nurses the knowledge and skills they need to successfully transition to radiology, blood and marrow transplant, outpatient infusion oncology, and Phase I/II research on a Precision Medicine Unit. Expert nurses and Master’s-prepared oncology educators provide hands-on orientation to entity-specific policies and procedures; training on core oncology nursing skills, such as central line care and maintenance, port access, safe drug administration, and hazardous spill clean-up; and preparation for the ONS/ONCC Chemotherapy Immunotherapy Certificate. Individualized preceptors work side-by-side with academy nurses upon transition to their units. 

    Learning Objectives:

    At the end of this educational activity, participants should be able to:

    • Discuss our experience of implementing an evidence-based transitional oncology training program to address staffing shortages
    • Describe specific elements needed to develop evidence-based oncology academy, including curriculum, baseline knowledge, skills, and expertise required to prepare non-oncology nurses for oncology practice
    • Describe lessons learned and key take-aways

    Faculty:

    Marguerite Rowell, MSN, MBA, MSM/HM, ONC, SCRN
    Assistant Vice President of Nursing
    Miami Cancer Institute, Baptist Health South Florida

    Hollie Gow, DNP, APRN, ACNP-BC, CCRN, PCCN CPHQ
    Director of Professional Nursing Practice & Performance Improvement|
    Miami Cancer Institute, Baptist Health South Florida

    Michele Ryder, MSN, MSHSA RN CEN
    Chief Operating Officer and Chief Nurse
    Miami Cancer Institute, Baptist Health South Florida

    ACCREDITED CONTINUING EDUCATION

    Accreditation Statement

    image

    In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and ACCC.  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Credit Designation for Nursing
    AXIS Medical Education designates this continuing nursing education activity for 0.5 contact hours.
    Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

    Healthcare Executives
    ACHE Qualified Education credit must be related to healthcare management (i.e., it cannot be clinical, inspirational, or specific to the sponsoring organization). It can be earned through educational programs conducted or sponsored by any organization qualified to provide education programming in healthcare management. Programs may be sponsored by ACHE, chapters, or other qualified sources, whether the programming is face-to-face or distance offerings (webinars, online seminars, self-study courses, etc.). You will receive a certificate of completion for 0.5 hours.

    AXIS Contact Information
    For information about the accreditation of this program please contact AXIS at info@axismeded.org.

    Disclosure of Conflicts of Interest
    AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

     

    Name of Faculty or Presenter/Planner

    Reported Financial Relationship

    Marguerite Rowell, MSN, MBA, MSM/HM, ONC, SCRN

    Nothing to disclose

    Hollie Gow, DNP, APRN, ACNP-BC, CCRN, PCCN CPHQ

    Nothing to disclose

    Michele Ryder, MSN, MSHSA RN CEN

    Nothing to disclose

    The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 

    Name of Planner/Manager/Reviewer

    Reported Financial Relationship

    Leigh Boehmer, PharmD, BCOP

    Nothing to disclose

    Christina Fuller, BSW

    Nothing to disclose

    Tom A. Gallo, MS, MDA

    Nothing to disclose

    Marilyn L. Haas-Haseman, PhD, RN, CNS, ANP-BC

    Nothing to disclose

    Monique J. Marino

    Nothing to disclose

    Rebecca McMahon

    Nothing to disclose

    Kerri Michalik, MHA, BSN

    Nothing to disclose

    Dee Morgillo, MEd., MT(ASCP), CHCP

    Nothing to disclose

    Barbara Schmidtman, PhD

    Nothing to disclose

    Disclaimer   

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

    Method of Participation and Request for Credit    

    • Attend/participate in the educational activity and review all course materials. 

    To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

    Hollie Gow

    Director of Professional Nursing Practice & Performance Improvement

    I have worked for Baptist Health South Florida (BHSF) for 15 years. In 2005, I began my career at BHSF as a Clinical Partner (care tech) at Baptist Hospital’s Critical Care Unit. In 2006, I began working as a Critical Care nurse after completing an associate’s degree in Nursing. I was able to continue my education and complete a bachelor's degree in Nursing (BSN) and master's degree in Nursing (MSN) with a specialization as an Acute Care Nurse Practitioner. In 2011, I began working as the Manager of Safety and Process Improvement for Critical Care, Progressive Care, and the Dialysis Unit. During that time, I completed a Doctorate Degree in Nursing Practice (DNP) in 2016. The Doctoral Capstone was a Clinical Protocol Change: Initiatives to Reduce Cather-Associated Urinary Tract Infections (CAUTI) in the Adult Critical Care Unit which decreased the CAUTI rate by 83% using an evidence-based practice prevention bundle. The American Nurses Credentialing Center (ANCC) recognized this exemplary work, and I was awarded the 2017 Certified Nurse Award, which was a true honor. I began working at the Miami Cancer Institute (MCI) in 2017 as the Director of Performance Improvement. Currently, I am working as the Director of Professional Nursing Practice Standards and Performance Improvement. This exciting role includes: all educational processes throughout the organization; oversight and development of the Transitional Academy for experienced nurses new to oncology; development of policies, procedures, and workflow processes; and all patient safety and accreditation activities.

    Marguerite Rowell

    Assistant Vice President of Nursing

    Marguerite Rowell is the Assistant Vice President of Nursing at Miami Cancer Institute in Miami Florida. She over twenty years of experience in nursing, specifically, 10 years in neuroscience and over 6 years in oncology. She has presented on multiple occasions on a local and national level. Marguerite has a BSN from Florida International University, MSN from Nova Southeastern University and, MBA and master's in health management from St. Thomas University

    Michele Ryder

    Cancer Center Program Administrator

    Ms. Ryder’s extensive professional background encompasses over 37 years in both patient care and executive positions. She is a clinical expert in hospital operations and has been responsible for the growth of the renowned neuroscience and surgical programs at Baptist Hospital of Miami, where she began her career 29 years ago in surgery and the post-anesthesia care unit.

    A member of the American College of Healthcare Executives and South Florida Organization of Healthcare Executives, Ms. Ryder also sits on the board of Living Hope Haiti. In this capacity, she has organized more than 24 Baptist Health surgical trips to the country, which provide life-changing surgery for Haitian residents in need.

    Ms. Ryder holds two master's degrees in nursing and healthcare administration from the University of St. Francis.

  • Utilizing Technology to Identify Patient Co-Morbidities and Reduce Hospital and ED Admissions

    Contains 5 Component(s), Includes Credits

    Presented at the 37th [Virtual] National Oncology Conference

    Utilizing Technology to Identify Patient Co-Morbidities and Reduce Hospital and ED Admissions

    ACCC 37th National Oncology Conference 

    This educational activity is jointly provided by AXIS Medical Education and ACCC

    This activity is supported by educational grants from Abbvie,  AstraZeneca, GlaxoSmithKline, Lilly and Pfizer, Inc.

    Release Date: 10/16/2020

    Expire Date: 10/15/2021

    Estimated Time to Complete: 75 minutes

    Target audience: Nurses, APPs, cancer program administrators, practice administrators, case managers and care coordinators, finance and HIT leaders

    Overview: After analysis of Oncology Care Model data identified three comorbid illnesses that led to significantly higher rates of unplanned emergency department (ED) visits and hospitalizations—COPD, congestive heart failure, and diabetes mellitus—Tennessee Oncology developed targeted management algorithms that proactively addressed these conditions. Today care coordinators use these algorithms to screen, identify, and help manage at-risk patients via the care management platform, either by patient-initiated contact, such as telephone triage, or through a patient health portal, depending on the patient’s access and comfort with this technology. For patients admitted to the ED or hospital, admission software provides real-time data to the practice to improve patient management and reduce length of stay and readmissions.

    Learning Objectives:

    At the end of this educational activity, participants should be able to:

    • Explain how access to real-time data can be used to develop targeted patient management algorithms.
    • Use these algorithms to identify patients at risk for ED visits and hospitalizations and then develop workflows to improve patient management, reduce ED visits, and decrease hospitalizations.
    • Demonstrate the use of these algorithms to become adept at identifying patients with co-morbidities and developing better management strategies to address them.

    Faculty:

    Larry Bilbrey, Care Data Systems Manager
    Care Data Systems Manager
    Tennessee Oncology

    Jonetta Blakely, MD, MS, MMHC
    Executive Director, Health and Economic and Outcome Research and
    Chairwoman, Performance Improvement Committee

    Tom Gallo, MS, MDA
    Executive Director
    Virginia Cancer Institute

    ACCREDITED CONTINUING EDUCATION

    Accreditation Statement

    image

    In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and ACCC.  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Credit Designation for Nursing
    AXIS Medical Education designates this continuing nursing education activity for 1.25 contact hours.
    Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

    Healthcare Executives
    ACHE Qualified Education credit must be related to healthcare management (i.e., it cannot be clinical, inspirational, or specific to the sponsoring organization). It can be earned through educational programs conducted or sponsored by any organization qualified to provide education programming in healthcare management. Programs may be sponsored by ACHE, chapters, or other qualified sources, whether the programming is face-to-face or distance offerings (webinars, online seminars, self-study courses, etc.). You will receive a certificate of completion for 1.25 hours.

    AXIS Contact Information

    For information about the accreditation of this program please contact AXIS at info@axismeded.org.

    Disclosure of Conflicts of Interest
    AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

    Name of Faculty or Presenter/Planner

    Reported Financial Relationship

    Larry Bilbrey

    Received income from: Tennessee Oncology, PLLC-Self

    Ownership interest: Hospital Corporation of America-Spouse

    Jonetta Blakely, MD, MS, MMHC 

    Contracted Research: Bristol Myers Squibb

    Tom Gallo,MS, MDA

    Nothing to disclose

    The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 

    Name of Planner/Manager/Reviewer

    Reported Financial Relationship

    Leigh Boehmer, PharmD, BCOP

    Nothing to disclose

    Christina Fuller, BSW

    Nothing to disclose

    Tom A. Gallo, MS, MDA

    Nothing to disclose

    Marilyn L. Haas-Haseman, PhD, RN, CNS, ANP-BC

    Nothing to disclose

    Monique J. Marino

    Nothing to disclose

    Rebecca McMahon

    Nothing to disclose

    Dee Morgillo, MEd., MT(ASCP), CHCP

    Nothing to disclose

    Kerri Michalik, MHA, BSN

    Nothing to disclose

    Barbara Schmidtman, PhD

    Nothing to disclose

    Disclaimer   

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

    Method of Participation and Request for Credit    

    • Attend/participate in the educational activity and review all course materials. 

    To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

    Larry Bilbrey

    Care Data Systems Manager

    Larry Bilbrey is the Care Data Systems Manager for Tennessee Oncology, where he is responsible for value-based care reporting to multiple government and commercial payers.

    Larry began his career at Tennessee Oncology almost 15 years ago. He has spent the majority of his time with Tennessee Oncology in operations. Prior to becoming the Care Data Systems Manager, Larry was a Regional Operations Manager for 7 years, and, prior to that, an Operations Manager. 

    There have been multiple projects that Larry has been involved in with Tennessee Oncology over the years. He has been a part of the Value Based Care project(s) at Tennessee Oncology since its origination in 2014. He has developed many aspects of Tennessee Oncology’s Value Based Care initiatives including navigation/care coordination and central triage. Larry has played an integral part in the original Medical Home pilot. This comprises of being the designer and product owner/administrator of Tennessee Oncology’s original proprietary telephone triage management tool.

    Johnetta Blakely

    Executive Director of Health Economics and Outcome Research ; Chairwoman, Performance Improvement Committee

    Johnetta Blakely holds the position of Executive Director of Health Economics and Outcomes Research for Tennessee Oncology, PLLC, one of the nation's largest community-based oncology practices. In her role she provides oversight for all outcomes research projects within Tennessee Oncology. She is responsible for direct oversight of protocol development, budgeting, data analysis, abstracting and presentation of data. She collaborates closely with technology vendors, pharma and other organizations to collaborate in these projects. She also provides suggestions and guides improvement based on the data from health outcomes projects. She also serves as the chair of the Performance Improvement committee for Tennessee Oncology which allows implementation of process improvement guided from outcomes.  She has maintained an active Hematology-Oncology practice for the past 15 years with an interest in breast cancer and lung cancer. 

    A diplomate of the American Board of Internal Medicine, she holds certification for Medical Oncology. She participates in clinical research and is published in leading medical journals. She maintains associations with professional organizations including the American Society of Clinical Oncology, American College of Physicians, Community Oncology Alliance, and Tennessee Medical Association.

    She earned her medical degree at the University of Tennessee, Memphis. She completed her Internal Medicine residency at the University of Texas, Houston, and her Medical Oncology fellowship at the University of Texas M.D. Anderson Cancer Center. She earned a master’s degree in Clinical Research from the University of Texas Health Science Center in Houston and a Masters in Management in Health Care from Vanderbilt University.

  • Improve Oral Oncolytic Workflow and Reduce Treatment Delays with a Pharmacist Collaborative Practice Agreement

    Contains 5 Component(s), Includes Credits

    Presented at the 37th [Virtual] National Oncology Conference

    Improve Oral Oncolytic Workflow and Reduce Treatment Delays with a Pharmacist Collaborative Practice Agreement

    ACCC 37th National Oncology Conference 

    This educational activity is jointly provided by AXIS Medical Education and ACCC

    This activity is supported by educational grants from Abbvie,  AstraZeneca, GlaxoSmithKline, Lilly and Pfizer, Inc.

    Release Date: 10/16/2020

    Expire Date: 10/15/2021

    Estimated Time to Complete: 75 minutes

    Target audience: Physicians, nurses, APPs, pharmacists, pharmacy technicians, cancer program administrators, practice administrators, quality managers

    Overview: Learn how a pharmacy resident project supported the creation and implementation of an oral oncolytic collaborative practice agreement (CPA) that expanded pharmacist scope of practice, decreased turnaround time for processing prescriptions, improved provider satisfaction, and decreased patient prescription costs. Today, St. Luke's Cancer Institute’s CPA allows pharmacists to sign prescriptions on behalf of providers for interventions such as renal or hepatic dose adjustments, dose rounding, renewal of prescription refills, adjustment for toxicities, dosing based on appropriate indication, and the ordering of laboratory tests and/or exams.

    Learning Objectives:

    At the end of this educational activity, participants should be able to:

    • Discuss the benefits of creating and implementing a collaborative pharmacist practice agreement to improve oral oncolytic workflow and reduce treatment delays

    Faculty:

    Amanda Wright, PharmD
    Oncology Pharmacist
    St. Luke's Cancer Institute

    Julia Kerr, PharmD
    Integrated Pharmacy Program Coordinator
    St. Luke's Cancer Institute

    ACCREDITED CONTINUING EDUCATION

    Accreditation Statement

    image

    In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and ACCC.  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    image

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    Credit Designation for Physicians
    AXIS Medical Education designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Credit Designation for Pharmacists
    This knowledge-based activity is approved for 1.25 contact hours of continuing pharmacy education credit JA4008106-9999-20-061-H01-P.

    Credit Designation for Nursing
    AXIS Medical Education designates this continuing nursing education activity for 1.25 contact hours.
    Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

    Healthcare Executives
    ACHE Qualified Education credit must be related to healthcare management (i.e., it cannot be clinical, inspirational, or specific to the sponsoring organization). It can be earned through educational programs conducted or sponsored by any organization qualified to provide education programming in healthcare management. Programs may be sponsored by ACHE, chapters, or other qualified sources, whether the programming is face-to-face or distance offerings (webinars, online seminars, self-study courses, etc.). You will receive a certificate of completion for 1.25 hours.

    AXIS Contact Information
    For information about the accreditation of this program please contact AXIS at info@axismeded.org.

    Disclosure of Conflicts of Interest
    AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

    Name of Faculty or Presenter/Planner

    Reported Financial Relationship

    Amanda Wright, PharmD

    Nothing to disclose

    Julia Kerr, PharmD

    Nothing to disclose

    The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 

    Name of Planner/Manager/Reviewer

    Reported Financial Relationship

    Leigh Boehmer, PharmD, BCOP

    Nothing to disclose

    Jay Carlson, DO

    Nothing to disclose

    Christina Fuller, BSW

    Nothing to disclose

    Tom A. Gallo, MS, MDA

    Nothing to disclose

    Marilyn L. Haas-Haseman, PhD, RN, CNS, ANP-BC

    Nothing to disclose

    Monique J. Marino

    Nothing to disclose

    Rebecca McMahon

    Nothing to disclose

    Kerri Michalik, MHA, BSN

    Nothing to disclose

    Dee Morgillo, MEd., MT(ASCP), CHCP

    Nothing to disclose

    Barbara Schmidtman, PhD

    Nothing to disclose


    Disclaimer   

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

    Method of Participation and Request for Credit    

    • Attend/participate in the educational activity and review all course materials. 

    To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

    Julia Kerr, PharmD

    Pharmacy Program Coordinator

    I graduated from the University of Wyoming School of Pharmacy in 2002.  I went on to complete the Oncology Pharmacy Residency Program at St. Luke’s Cancer Institute in Boise, Idaho, the following year. Upon completion, I accepted an oncology pharmacy position at St. Luke’s where I worked for many years in the outpatient infusion pharmacy. For the past several years, I have transitioned to working exclusively with the Oral Oncology Pharmacy Program at St. Luke’s.  And in recent years, I have been the Pharmacy Program Coordinator for this department. I have had the pleasure of precepting many oncology pharmacy residents over the years and have enjoyed the opportunity to work with them on valuable projects, such as the one being presented at ACCC. I am also an active member with the National Community Oncology Dispensing Association (NCODA), where I currently serve as a Regional Leader.

    Amanda Wright

    Clinical Oncology Pharmacist

    Amanda Wright, PharmD, has been a clinical oncology pharmacist since 2019. She received a bachelor’s degree in microbiology from the University of Idaho in 2013 and her Doctor of Pharmacy degree from Washington State University in 2017. Dr. Wright completed a generalized hospital pharmacy residency at St. Luke’s Boise Medical Center, and a specialized oncology pharmacy residency at St. Luke’s Cancer Institute, formerly Mountain States Tumor Institute. She currently works in the medically integrated pharmacy at St. Luke’s Cancer Institute and on the adult oncology floor in the St. Luke’s Boise Medical Center. Dr. Wright has been involved in the creation and implementation of the oral oncolytic collaborative practice agreement over the last two years. She enjoys spending her free time with her family and two Golden Retrievers and helps on the family cattle ranch when able.

  • Leveraging a 3D Lung Nodule Educational Tool to Reduce Patient Distress

    Contains 1 Component(s)

    Presented at the 37th [Virtual] National Oncology Conference

    Gary Hochheiser

    Director of Thoracic Surgery and Thoracic Oncology; Medical Director, Lung Screening Program

    As the Director of Thoracic Surgery and Thoracic Oncology and Medical Director for the Lung Screening Program at Maine Medical Center, I specialize in minimally invasive procedures in the treatment of thoracic diseases, including both benign and malignant diseases of the lung, esophagus, and pleura, along with the surgical treatment of lung and esophageal cancer as well as lung-sparing cancer surgery. As a past instructor of minimally thoracic procedures, I also have an interest in both benign and malignant diseases of the esophagus including reflux, hiatal hernia and esophageal motility disorders.

    Theresa Roelke

    Geriatric Nurse Practitioner

    Theresa Roelke, GNP Theresa is a Geriatric Nurse Practitioner for Maine Medical Center (MMC) where she manages a comprehensive, patient-centered Lung Screening Program which focuses on lung health. Theresa is part of the Northern New England Clinical and Translational Research Network where she supports research and protocol review for Maine Medical Center Research Institute. She also supports the Maine Lung Cancer Coalition which serves to increase lung screening and lung screening awareness across Maine. Additionally, Theresa serves on the Maine Cancer Foundation/ CDC 2021-2025 Maine Cancer Plan, the American Cancer Society Tobacco Treatment Roundtable, is part of the MaineHealth 2020 Innovator Cohort and the 2020 MaineHealth Provider Leadership Fellowship. In addition to her clinical duties, Theresa is involved in several Maine Health initiatives such as bringing lung screening across MaineHealth in an effort to bring lung screening to rural Mainers and projects that involve the use of 3D modeling and virtual reality to help engage and educate patients on disease and disease prevention while encouraging health stewardship. She is also leading a project to build portable units to deactivate viral particles on filtered face mask using UV light called, UV LAVE™. Two prototypes will be introduced Fall 2020 for use in clinical settings.

  • A Nurse Navigator-Led Community-Based Cardio-Oncology Clinic

    Contains 5 Component(s), Includes Credits

    Presented at the 37th [Virtual] National Oncology Conference

    A Nurse Navigator-Led Community-Based Cardio-Oncology Clinic

    ACCC 37th National Oncology Conference

    This educational activity is jointly provided by AXIS Medical Education and ACCC

    This activity is supported by educational grants from Abbvie,  AstraZeneca, GlaxoSmithKline, Lilly and Pfizer, Inc.

    Release Date: 10/16/2020

    Expire Date: 10/15/2021

    Estimated Time to Complete: 75 minutes

    Target audience: Physicians, nurses, APPs, nurse navigators, cancer program administrators, practice administrators

    Overview: Hear how this program grew from manual chart mining to identify at-risk patients into a program sustained by robust referrals from providers looking for the specialized expertise of cardio-oncologists. Today Franciscan Health Cancer Center Indianapolis manages the cardio-toxic side effects of more than 1,000 cancer patients. Working in collaboration with medical oncologists and other members of the multidisciplinary team, the cardio-oncology team helps keep oncology patients in treatment and works to improve patient quality of life. Gain additional perspective from an educational video that chronicles a patient’s journey through the clinic.

    Learning Objectives:

    At the end of this educational activity, participants should be able to:

    • Discuss the importance of educating clinicians, administrators, patients, and other key stakeholders, such as payers, about the cardio-toxic effects of cancer treatment.
    • Demonstrate why the disciplines of medical oncology and cardiology must establish interdepartmental collaboration to identify at-risk patients and improve the management of these cancer patients.
    • Explain how a nurse navigator can act as a bridge between these two disciplines to improve care coordination and the patient experience.

    Faculty:

    Vijay Rao, MD, PhD, FACC, FASE, FHFSA
    Director, CardioOncology
    Co-Director, Heart Failure Program and Anti-coagulation Clinic Franciscan Health Cancer Center Indianapolis

    Kerry Skurka, RN, BSN
    Cardio-Oncology Nurse Navigator Franciscan Health Cancer Center Indianapolis

    Peter Garrett, MD FACR
    Medical Director of Cancer Services and Radiation Oncology
    Franciscan Health Cancer Center Indianapolis

    ACCREDITED CONTINUING EDUCATION

    Accreditation Statement

    image

    In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and ACCC.  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Credit Designation for Nursing
    AXIS Medical Education designates this continuing nursing education activity for 1.25 contact hours.
    Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

    AXIS Contact Information
    For information about the accreditation of this program please contact AXIS at info@axismeded.org.

    Disclosure of Conflicts of Interest
    AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

    Name of Faculty or Presenter/Planner

    Reported Financial Relationship

    Vijay Rao, MD, PhD, FACC, FASE, FHFSA

    Speakers Bureau: BI, BMS, Novartis, Pfizer

    Kerry Skurka, RN, BSN

    Nothing to disclose

    Peter Garrett, MD FACR

    Nothing to disclose

    The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 

    Name of Planner/Manager/Reviewer

    Reported Financial Relationship

    Leigh Boehmer, PharmD, BCOP

    Nothing to disclose

    Christina Fuller, BSW

    Nothing to disclose

    Tom A. Gallo, MS, MDA

    Nothing to disclose

    Marilyn L. Haas-Haseman, PhD, RN, CNS, ANP-BC

    Nothing to disclose

    Monique J. Marino

    Nothing to disclose

    Rebecca McMahon

    Nothing to disclose

    Kerri Michalik, MHA, BSN

    Nothing to disclose

    Dee Morgillo, MEd., MT(ASCP), CHCP

    Nothing to disclose

    Barbara Schmidtman, PhD

    Nothing to disclose



    Disclaimer  
     

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

    Method of Participation and Request for Credit    

    • Attend/participate in the educational activity and review all course materials. 

    To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

    Peter Garrett

    Medical Director of Cancer Services and Radiation Oncology

    Dr. Garrett is the Medical Director of Cancer Services and Radiation Oncology at Franciscan St. Francis Hospital located on the Southside of Indianapolis, Indiana.

    Dr. Garrett graduated from Queen’s University located in Kingston, Ontario in 1977. After graduating from Medical School he did an Internship in General Medicine through Queens University followed by a Radiation Oncology Residency and Fellowship at the University of Toronto through Princess Margaret Hospital in Toronto, Ontario completing his program in 1981.

    During Dr. Garrett’s tenure as a Radiation Oncologist, he has participated in many professional societies and professional committees. Dr. Garrett has also participated and continues to participate in several medical research groups and has been published multiple times.

    Vijay Rao

    Cardiologist

    A member of Franciscan Physician Network Indiana Heart Physicians (IHP), Dr. Rao practices at Franciscan Health Indianapolis and also sees patients at clinics in Greensburg and Greencastle. He is board-certified in internal medicine, cardiovascular disease, echocardiography, nuclear cardiology, and advanced heart failure and transplant cardiology.

    Dr. Rao received his undergraduate degree in biology from DePauw University and earned his medical degree at Medical University of South Carolina in Charleston. He completed an internal medicine residency at Duke University Medical Center and later completed fellowships in cardiology and echocardiography at the University of California (San Francisco), where he also was a clinical instructor in cardiology. Dr. Rao also has a PhD in molecular and cellular biology and pathobiology from the University of South Carolina.

    He is a Diplomate of the American Board of Internal Medicine, Fellow of the American College of Cardiology and Fellow of the American Society of Echocardiography

    He was instrumental in helping establishing an inpatient heart failure unit and coordinating heart failure care to reduce heart failure readmissions. Dr. Rao also played a key role in launching a cardio-oncology clinic that promotes collaboration between oncologists and cardiologists to help cancer patients successfully complete their cancer treatment with the goal of minimizing potential cardio-toxic effects of certain chemotherapy drugs.

    Kerry Skurka

    Cardio-Oncology Nurse Navigator

    For the last 40 years, Kerry Skurka has been a practicing registered nurse and leader in cardiology, critical care and emergency medicine. In 2011, Kerry left her leadership role to switch gears as she wanted to once again care for patients at the bedside. In 2014, Kerry became an infusion nurse at Franciscan Health, where she quickly noticed cardiac issues in her oncology patients. Her cardiac nursing background and leadership experience then took her down the less-traveled path of cardio-oncology, which led to her becoming the first cardio-oncology nurse navigator at Franciscan Health in 2016. For Kerry, cancer care was personal. She was diagnosed with Non-Hodgkin’s Lymphoma in 2008 and stood by her husband’s side in 2013 as he was diagnosed with head and neck cancer and later passed away from Non-Hodgkin’s Lymphoma in 2017. As a cancer survivor herself, becoming the cardio-oncology nurse navigator at Franciscan was a natural fit that fueled a new passion in making a difference in cancer survivorship. Kerry’s passion about cardio-oncology is ever evident as she has lobbied both at the state and national levels; submitted multiple poster projects at various conferences; and strives to educate everyone she meets, because in her own words: cardio-oncology affects patients every day in every community.

  • Reducing ED Visits and Hospital Admissions after Chemotherapy with Predictive Modeling of Risk Factors

    Contains 5 Component(s), Includes Credits

    Presented at the 37th [Virtual] National Oncology Conference

    Reducing ED Visits and Hospital Admissions after Chemotherapy with Predictive Modeling of Risk Factors

    ACCC 37th National Oncology Conference 

    This educational activity is jointly provided by AXIS Medical Education and ACCC

    This activity is supported by educational grants from Abbvie,  AstraZeneca, GlaxoSmithKline, Lilly and Pfizer, Inc.

    Release Date: 10/16/2020

    Expire Date: 10/15/2021

    Estimated Time to Complete: 75 minutes

    Target audience: Physicians, nurses, APPs, pharmacists, pharmacy technicians, cancer program administrators, practice administrators, quality managers

    Overview: After conducting a retrospective review to identify clinical variables associated with increased risk of hospital admissions and emergency department visits, Mercy Cancer Care used these data to develop and implement a predictive algorithm that stratifies patients according to their 30-day risk of both events. A daily dashboard report identifies all patients as high, intermediate, or low risk. These dashboard risk scores are then used to proactively manage patients with referrals to services such as social work, dietitian, or evaluation for possible home care assistance. Ultimately, this QI initiative effort will allow proactive management of patients within 30 days of their outpatient chemotherapy—the OP 35 bundling payment initiative that CMS put into effect this year under its Hospital Outpatient Quality Reporting Program. 

    Learning Objectives:

    At the end of this educational activity, participants should be able to:

    • Identify clinical variables associated with increased risk of hospital and emergency department admissions using predictive modeling
    • Use the above variables to proactively manage patients with cancer to reduce readmissions after chemotherapy

    Faculty:

    Michelle Smith, DC, Director Oncology Services Mercy Cancer Care
    Jay Carlson, DO, Obstetrician-Gynecologist
    Mercy Hospital

    Christina Fuller, BSW
    Oncology Patient Financial Navigator
    Mosaic Life Care Cancer Care

    ACCREDITED CONTINUING EDUCATION

    Accreditation Statement

    image

    In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and ACCC.  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    image

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    Credit Designation for Physicians
    AXIS Medical Education designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Credit Designation for Nursing
    AXIS Medical Education designates this continuing nursing education activity for 1.25 contact hours.
    Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

    Healthcare Executives
    ACHE Qualified Education credit must be related to healthcare management (i.e., it cannot be clinical, inspirational, or specific to the sponsoring organization). It can be earned through educational programs conducted or sponsored by any organization qualified to provide education programming in healthcare management. Programs may be sponsored by ACHE, chapters, or other qualified sources, whether the programming is face-to-face or distance offerings (webinars, online seminars, self-study courses, etc.). You will receive a certificate of completion for 1.25 hours.

    AXIS Contact Information
    For information about the accreditation of this program please contact AXIS at info@axismeded.org.

    Disclosure of Conflicts of Interest
    AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

    Name of Faculty or Presenter/Planner

    Reported Financial Relationship

    Michelle Smith, DC

    Nothing to disclose

    Jay Carlson, DO

    Nothing to disclose

    Christina Fuller, BSW

    Nothing to disclose

    The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 

    Name of Planner/Manager/Reviewer

    Reported Financial Relationship

    Leigh Boehmer, PharmD, BCOP

    Nothing to disclose

    Jay Carlson, DO

    Nothing to disclose

    Christina Fuller, BSW

    Nothing to disclose

    Tom A. Gallo, MS, MDA

    Nothing to disclose

    Marilyn L. Haas-Haseman, PhD, RN, CNS, ANP-BC

    Nothing to disclose

    Monique J. Marino

    Nothing to disclose

    Rebecca McMahon

    Nothing to disclose

    Kerri Michalik, MHA, BSN

    Nothing to disclose

    Dee Morgillo, MEd., MT(ASCP), CHCP

    Nothing to disclose

    Barbara Schmidtman, PhD

    Nothing to disclose


    Disclaimer  
     

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

    Method of Participation and Request for Credit    

    • Attend/participate in the educational activity and review all course materials. 

    To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

    Jay Carlson

    Principal Investigator

    Cancer Research for the Ozarks (Ozarks Regional CCOP)Springfield

    Mercy Clinic – Women’s OncologySpringfield

    During his 24 years of military service, Dr. Carlson earned a position as OB/GYN consultant to the office of the Surgeon General and received the prestigious Surgeon General’s Physician Award for 2000. He served at Walter Reed Medical Center as Chief of the OB/GYN Department and as Chief of the Division of Gynecologic Oncology.  Dr. Carlson is a two-time recipient of the National Faculty Award for Excellence in Resident Education and has published more than 70 works related to his field.

    Michelle Smith

    Director of Oncology Services

    Michelle Smith currently serves as Director of Oncology Services for Mercy Hospital St. Louis and has been with Mercy since 2001 in various roles.  Ms. Smith is the administrative lead for the Mercy Health Ministry Oncology Specialty Counsel. This specialty counsel is the driver behind the many changes Mercy oncology programs are working to incorporate across their ministry to both better patient experience and the outcomes for patients. Smith has a passion for oncology and specifically improving the quality of life for this patient population in seamless and innovative ways. The OP35 measure is one of many improved outcomes projects she has worked towards.  Other projects have included nurse navigation and standardization of infusion practices.  

  • Shifting Chemo Administration from Inpatient to Outpatient Setting Improves Care and Reduces Costs

    Contains 5 Component(s), Includes Credits

    Presented at the 37th [Virtual] National Oncology Conference

    Shifting Chemo Administration from Inpatient to Outpatient Setting Improves Care and Reduces Costs

    ACCC 37th National Oncology Conference 

    This educational activity is jointly provided by AXIS Medical Education and ACCC

    This activity is supported by educational grants from Abbvie,  AstraZeneca, GlaxoSmithKline, Lilly and Pfizer, Inc.

    Release Date: 10/16/2020

    Expire Date: 10/15/2021

    Estimated Time to Complete: 75 minutes

    Target audience: Physicians, nurses, APPs, pharmacists, pharmacy technicians, cancer program administrators, practice administrators, quality managers

    Overview: At the University of Arizona Cancer Center, Banner University Medical Center Tucson, a multidisciplinary team of physicians, pharmacy staff, finance specialists, social workers, nursing staff, and information technologists first identified chemotherapy regimens administered in the inpatient setting that could be safely administered in the outpatient setting, and then implemented a transition plan that included provider and patient education. Benefits included reduced inpatient medical resources and chemotherapy costs, decreased inpatient bed stay, lower infection rates, improved quality of life, and decreased overall cost of care—conservatively estimated at almost $6 million.

    Learning Objectives:

    At the end of this educational activity, participants should be able to:

    • Discuss why transitioning select chemotherapy regimens to the outpatient setting may be advantageous to cancer programs.
    • Adapt a transition plan to administer chemotherapy in the outpatient setting to lower infection rates, improve quality of life, and reduce cost of care.
    • Demonstrate metrics which may be used to document successful transition of select chemotherapy  regimens to the outpatient setting.

    Faculty:

    Ali McBride, PharmD, MS
    Daniel Persky, MD
    The University of Arizona Cancer Center
    Banner University Medical Center Tucson
    Tucson, AZ

    Kerri Michalik, MHA, BSN
    Vice President, Cancer Services
    Geisinger Health System, Geisinger Cancer Institute

    ACCREDITED CONTINUING EDUCATION

    Accreditation Statement

    image

    In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and ACCC.  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    image

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    Credit Designation for Physicians
    AXIS Medical Education designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Credit Designation for Pharmacists
    This knowledge-based activity is approved for 1.25 contact hours of continuing pharmacy education credit JA4008106-9999-20-068-H01-P.

    Credit Designation for Nursing
    AXIS Medical Education designates this continuing nursing education activity for 1.25 contact hours.
    Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

    Healthcare Executives
    ACHE Qualified Education credit must be related to healthcare management (i.e., it cannot be clinical, inspirational, or specific to the sponsoring organization). It can be earned through educational programs conducted or sponsored by any organization qualified to provide education programming in healthcare management. Programs may be sponsored by ACHE, chapters, or other qualified sources, whether the programming is face-to-face or distance offerings (webinars, online seminars, self-study courses, etc.). You will receive a certificate of completion for 1.25 hours.

    AXIS Contact Information
    For information about the accreditation of this program please contact AXIS at info@axismeded.org.

    Disclosure of Conflicts of Interest
    AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

    Name of Faculty or Presenter/Planner

    Reported Financial Relationship

    Ali McBride, PharmD, MS, BCOP

    Consultant: Pfizer

    Speaker's Bureau: Cohens

    Daniel Persky, MD

    Consultant: Bayer, Celgene, Cellectar Biosciences, Kymera Therapeutics,  Debiopharm (IDMC), MorphoSys and Sandoz.

    Kerri Michalik, MHA, BSN

    Nothing to disclose

    The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 

     

    Name of Planner/Manager/Reviewer

    Reported Financial Relationship

    Leigh Boehmer, PharmD, BCOP

    Nothing to disclose

    Christina Fuller, BSW

    Nothing to disclose

    Tom A. Gallo, MS, MDA

    Nothing to disclose

    Marilyn L. Haas-Haseman, PhD, RN, CNS, ANP-BC

    Nothing to disclose

    Monique J. Marino

    Nothing to disclose

    Rebecca McMahon

    Nothing to disclose

    Kerri Michalik, MHA, BSN

    Nothing to disclose

    Dee Morgillo, MEd., MT(ASCP), CHCP

    Nothing to disclose

    Barbara Schmidtman, PhD

    Nothing to disclose

    Disclaimer  

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

    Method of Participation and Request for Credit    

    • Attend/participate in the educational activity and review all course materials. 

    To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

    Ali McBride, PharmD, MS, BCOP

    Clinical Coordinator of Hematology/Oncology, The University of Arizona Cancer Center

    Ali McBride, PharmD, MS, BCOP, is the Clinical Coordinator of Hematology/Oncology at The University of Arizona Cancer Center. Currently serving on the Board of the Association of Community Cancer Centers (ACCC), Dr. McBride also chairs the Awards Selection Committee as well as the Corporate Development Committee. In addition to being a long-time ACCC member, Dr. McBride has been actively involved with the American Society of Health-System Pharmacists (ASHP) and the Hematology/Oncology Pharmacy Association (HOPA).

    Dr. McBride has been working on oncology drug shortages and has testified on behalf of HOPA at the U.S. Food and Drug Administration (FDA) Drug Shortage Workshop; presented on behalf of ACCC at the Washington, D.C., Congressional Session; and was an invited member of the ASHP Drug Shortage Stakeholders Meeting. Dr. McBride is also actively involved with biosimilar regulation and the pharmacoeconomic impact of biosimilars into the U.S. marketplace. He currently serves as a working group member for HOPA on its biosimilar committee. In addition, he serves on the National Quality Forum Cancer Standing Committee. He has published numerous articles on drug shortages, oral chemotherapy adherence, stem cell transplant, and biosimilar implementation into the U.S. healthcare market.

    Dan Persky

    Associate Professor of Medicine

    Dr. Persky serves as an Associate Professor of Medicine at the University of Arizona College of Medicine.  He is currently the Associate Director of the Clinical Investigations and Therapeutic Development Program.  He specializes in Hematology/Oncology, particularly in lymphoid malignancies, such as lymphoma, CLL, and others.

    Dr. Persky received his bachelor's degree from Harvard University and his medical degree from the Albert Einstein College of Medicine in New York.  He completed his internship and residency at the Mayo Graduate School of Medicine in Rochester, Minnesota, then returned to New York to complete a three-year fellowship in Medical Oncology and Hematology at the Memorial Sloan-Kettering Cancer Center.

    Dr. Persky is board certified by the American Board of Internal Medicine, sub-specialty of Medical Oncology.

  • Integration of Prehabilitation, Rehabilitation and Prospective Surveillance Into Cancer Interdisciplinary Teams

    Contains 5 Component(s), Includes Credits

    Presented at the 37th [Virtual] National Oncology Conference

    Integration of Prehab, Rehab, and Prospective Surveillance into Interdisciplinary Teams

    ACCC 37th National Oncology Conference 

    This educational activity is jointly provided by AXIS Medical Education and ACCC

    This activity is supported by educational grants from Abbvie,  AstraZeneca, GlaxoSmithKline, Lilly and Pfizer, Inc.

    Release Date: 10/16/2020

    Expire Date: 10/15/2021

    Estimated Time to Complete: 75 minutes

    Target audience: Nurses, APPs, nurse navigators, rehabilitation specialists, physical therapists, cancer program administrators, practice administrators

    Overview: Learn how Beaumont Cancer Institute implemented these services and improved the patient experience, reduced hospital length of stay, and facilitated early identification of physical impairments, functional limitations, and/or treatment restrictions. Other key outcomes include reduction of cancer-related fatigue, lymphedema, and falls, and non-opioid pain management. Then hear about the important role rehabilitation played in palliative care for patients with advanced cancer by optimizing quality of remaining life and minimizing unwarranted hospital readmissions. Patient case-based scenarios and video vignettes demonstrate how to integrate and sustain these services into cancer care, including necessary training for team members.         

    Learning Objectives:

    At the end of this educational activity, participants should be able to:

    1. State the importance of prehabilitation in immediate and late-effect outcomes of cancer survivors
    2. Identify key opportunities within individual healthcare systems to integrate prehabilitation, rehab and prospective surveillance concepts
    3. Explain to an uncomplicated patient the basics of safe, effective cardiovascular exercise in preparation for cancer treatments
    4. Identify and refer complex patients that may require an oncology rehabilitation therapist to provide prehabilitation or formal rehabilitation

    Faculty:

    Christopher Wilson, PT, DPT, DScPT, Residency Director, Oncologic Rehabilitation

    Reyna Colombo, PT, MA, Director of Rehabilitation Services Beaumont Health System, Beaumont Cancer Institute

    Jannifer S. Stromberg, MD, Medical Director, Wilscon Cancer Resource Center; Clinical Assistant professor, OUWB School of Medicine

    ACCREDITED CONTINUING EDUCATION

    Accreditation Statement

    image

    In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and ACCC.  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Credit Designation for Nursing
    AXIS Medical Education designates this continuing nursing education activity for 1.25 contact hours.
    Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

    Healthcare Executives
    ACHE Qualified Education credit must be related to healthcare management (i.e., it cannot be clinical, inspirational, or specific to the sponsoring organization). It can be earned through educational programs conducted or sponsored by any organization qualified to provide education programming in healthcare management. Programs may be sponsored by ACHE, chapters, or other qualified sources, whether the programming is face-to-face or distance offerings (webinars, online seminars, self-study courses, etc.). You will receive a certificate of completion for 1.25 hours.

    AXIS Contact Information
    For information about the accreditation of this program please contact AXIS at info@axismeded.org.

    Disclosure of Conflicts of Interest
    AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

    Name of Faculty or Presenter/Planner

    Reported Financial Relationship

    Christopher Wilson, PT, DPT, DScPT

    Nothing to disclose

    Reyna Colombo, PT, MA

    Nothing to disclose

    The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 

     

    Name of Planner/Manager/Reviewer

    Reported Financial Relationship

    Leigh Boehmer, PharmD, BCOP

    Nothing to disclose

    Christina Fuller, BSW

    Nothing to disclose

    Tom A. Gallo, MS, MDA

    Nothing to disclose

    Marilyn L. Haas-Haseman, PhD, RN, CNS, ANP-BC

    Nothing to disclose

    Monique J. Marino

    Nothing to disclose

    Rebecca McMahon

    Nothing to disclose

    Kerri Michalik, MHA, BSN

    Nothing to disclose

    Dee Morgillo, MEd., MT(ASCP), CHCP

    Nothing to disclose

    Barbara Schmidtman, PhD

    Nothing to disclose

    Disclaimer  

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

    Method of Participation and Request for Credit    

    • Attend/participate in the educational activity and review all course materials. 

    To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

    Reyna Colombo

    Reyna Colombo, MA, PT, is the director of physical and occupational therapy services at Beaumont Health, Troy Hospital. She is also the Past-President of the Michigan Physical Therapy Association’s Oncology Special Interest Group, a board member of the Oakland University School of Health Sciences Advisory Board and is an active member at the Michigan Cancer Consortium.

    She has spoken nationally and internationally on the administrative structure of development and sustainability of cancer rehabilitation programs, has numerous publications in cancer rehabilitation and care of those with chronic diseases, and is a recipient of the MPTA’s Marjorie Stamm Award for Outstanding Professional Service. Her leadership and management expertise led to the development of multiple rehabilitation clinics and a variety of specialty programs designed variety of clinics to improve health and wellness in the community. 

    Colombo is actively engaged in collaborative research projects with Oakland University. Her PRISM philosophy challenges therapist to embrace prevention, intervention, and sustainable wellness across the continuum of care. Her efforts and passion helped develop and implement Beaumont’s Cancer Survivorship and Rehabilitation Program, designed to provide comprehensive wellness education to patients diagnosed with cancer at the earliest point in their care to preserve function and quality of life. She spearheaded the development of one of the first Comprehensive Rehab Programs in the state of Michigan and was a lead in the creation of the first Oncology Residence Program in the United State through the American Physical Therapy Association.

    Jannifer Stromberg

    Medical Director, Wilson Cancer Resource Center

    Jannifer Stromberg, MD, received her bachelor’s degree in cellular and molecular biology from the University of Michigan and is a graduate of the University of Michigan Medical School. She completed her radiation oncology residency at Beaumont and is certified by the American Board of Radiology. She is an assistant professor at Oakland University William Beaumont School of Medicine and serves as the medical director of the Wilson Cancer Resource Center at Beaumont Hospital, Troy. She co-leads the thoracic multidisciplinary lung clinics at Beaumont and has been instrumental in developing supportive care services for cancer patients, including psychosocial oncology services, oncology rehabilitation and survivorship care programs. She maintains a diverse clinical practice and participates in the multidisciplinary care of breast, lung, head and neck, lymphoma and colorectal cancer patients. She also has an interest in cancer care for the elderly. She has published more than 30 peer-reviewed articles and continues to participate in Beaumont-initiated research as well national cooperative group trials.

    Chris Wilson

    Residency Program Director

    Dr. Wilson is an Assistant Professor at Oakland University and the residency program director for the Beaumont Health Oncology Residency. He is board certified in geriatric physical therapy. His clinical practice is in cancer physical therapy and acute care. Dr. Wilson’s research agenda focuses on palliative care physical therapy and the management of late-stage chronic illnesses. He teaches geriatrics, pharmacology, biophysical agents, and acute care in Oakland University’s Physical Therapy Program.  He is co-principal and co-founder of HOP-UP-PT, LLC.

    Chris received his Doctor of Science in Physical Therapy from Oakland University in 2015.  He received his transitional Doctor in Physical Therapy from University of St. Augustine with a Primary Care Certification and his master's in physical therapy from Oakland University in 2001.